Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.
about
Video-assisted thoracic surgery (VATS) lobectomy: the evidence baseGeriatric oncology: problems with under-treatment within this populationPostlobectomy Early ComplicationsTreatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysisPercutaneous lung biopsy: technique, efficacy, and complicationsTowards optimal pathologic staging of resectable non-small cell lung cancerVATS anatomic lung resections-the European experienceNon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipRandomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 TPostoperative mortality is an inadequate quality indicator for lung cancer resection.Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancerImproved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines.Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients.Surgical strategies in the therapy of non-small cell lung cancer.Risk factors for postoperative complications after lung resection for non-small cell lung cancer in elderly patients at a single institution in China.Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancerAudit of lymphadenectomy in lung cancer resections using a specimen collection kit and checklistThe role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms.Predictors and outcomes of limited resection for early-stage non-small cell lung cancerMinimally invasive electro-magnetic navigational bronchoscopy-integrated near-infrared-guided sentinel lymph node mapping in the porcine lungRadiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studiesLong-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.Computed tomographic screening for lung cancer.CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung CancerAmerican College of Surgeons Oncology Group and the community surgeon.Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.A lobe-specific lymphadenectomy protocol for solitary pulmonary nodules in non-small cell lung cancer.Resectable left lower lobe non-small cell lung cancer with lymph node metastasis is related to unfavorable outcomes.Metrics to assess quality of life after management of early-stage lung cancer.
P2860
Q24605093-EBE918F1-F8D2-488C-96C4-9D85D48B0F78Q26771401-C4F271D7-2DA8-40E8-9536-2783E269CB49Q26799516-2F770FA9-91E4-4A86-ABF2-CABE4CBDD608Q26853124-04A10FBF-834F-4EF6-BFD1-7AE4BEDE53C5Q26859343-27A543F3-055F-4A56-A893-30D425898A02Q26862737-E5417B7B-70C8-46A9-898A-5C42B9DCBA32Q26991912-CF1757FB-865A-44C4-822A-EF6964181EA2Q27026046-2C281766-ED8C-4FF3-B6A1-68CB1C75620FQ28278682-764A5325-39AA-45EA-8774-CCA0B897EFAFQ30355704-F06939AD-E965-46EF-ADDD-AD70DB1CBAF7Q30407624-CD8C7827-5A91-49FF-B028-E15D58B62398Q30424325-76944672-AE88-42A7-92BF-71910BA9602DQ30427048-F2E7A9CC-58A8-4F8A-9202-02A2BDBE5570Q30543321-38D4A8CD-A8BF-46B3-947E-427A439BC3D7Q30656342-950AE99D-4CF0-4E40-BF7F-763D055A55E5Q30845191-6CBED365-287D-441D-89D0-F266EBB84ACDQ30857091-F1D6DA56-545D-41AE-B963-4CCB22483C22Q30985297-008BF2B8-13BC-4907-9FFA-2CCCA982A2D7Q30993385-D30D05EA-884D-4466-ABF1-6A92785FEF21Q33773923-7C773C01-8AD6-4F32-A611-D78D1A40A689Q33811206-5EE032C7-9C1B-47F6-B890-DCE8816D2CBEQ33846146-92A55B95-6D52-451D-93A1-38B78B60DBFEQ34031208-3E735130-D7AD-45EB-A3C7-174B63B9B75BQ34258296-4425FF79-CB1B-446C-BF9D-EAE5EBC5AF80Q34435251-6D88FE93-34D6-4683-B367-6CDB0D21825AQ34821980-003115A9-D399-48EF-8212-74EDEC747997Q35039977-7FC7A3F2-2B39-4A1B-9D50-E87B2CB8898FQ35113011-CFF03A3F-9EEB-4C2A-85EE-CC871A8055D5Q35500062-3112203C-A58E-4D48-AFC9-DDC06D120C97Q35636431-8FC4AF7C-D809-41AF-A3D1-10859E5F4CF0Q35764518-FC1AB8EF-E680-415C-8153-F5DBBC6B04C0Q35803022-A7BF0B3B-CA05-47E5-8721-D96DC0381489Q35923256-97234F69-DBF6-41F0-8F6B-4D475E5318D3Q35942111-1A355938-F24B-4D35-8238-846C5E2E35A6Q35972485-2FA6505D-F7F9-4295-A197-27A2A6474200Q36078160-5748EC0D-C97B-4354-A8DE-8671D2F33284Q36162516-DB86145C-F158-477A-9187-97A58E0B9EB7Q36419105-8B2BEA2A-BF15-445D-AA2E-2C579C8B5EBAQ36439723-EC98F8D3-4DD6-4C49-BDB5-E86407A2E425Q36486055-DD92998B-C695-4F8B-9A71-87F73D9F634A
P2860
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Morbidity and mortality of maj ...... rospective ACOSOG Z0030 trial.
@en
type
label
Morbidity and mortality of maj ...... rospective ACOSOG Z0030 trial.
@en
prefLabel
Morbidity and mortality of maj ...... rospective ACOSOG Z0030 trial.
@en
P2093
P1476
Morbidity and mortality of maj ...... prospective ACOSOG Z0030 trial
@en
P2093
ACOSOG Z0030 Study Group
Bryan F Meyers
David H Harpole
David R Jones
Gail E Darling
James E Herndon
Joe B Putnam
John D Mitchell
Mark S Allen
Richard I Inculet
P304
1013-9; discussion 1019-20
P356
10.1016/J.ATHORACSUR.2005.06.066
P407
P577
2006-03-01T00:00:00Z